Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 475-487
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.475
Table 2 Association of covariates and diabetic kidney disease risk
Variables
OR (95%CI)
P value
Age (yr)1.04 (1.04-1.05)< 0.001
Sex, n (%)
Male1 (reference)
Female0.93 (0.84-1.03)0.178
Race/ethnicity, n (%)
Non-Hispanic white1 (reference)
Non-Hispanic black1.11 (0.97-1.27)0.115
Mexican American0.80 (0.69-0.93)0.003
Others0.72 (0.62-0.83)< 0.001
Educational level (yr), n (%)
< 91 (reference)
9-120.97 (0.84-1.12)0.651
> 120.73 (0.63-0.85)< 0.001
Marital status, n (%)
Married or living with a partner1 (reference)
Living alone1.45 (1.31-1.61)< 0.001
Family income, n (%)
Low1 (reference)
Medium0.96 (0.85-1.08)0.466
High0.62 (0.54-0.72)< 0.001
BMI (kg/m2)1.00 (0.99-1.01)0.605
Smoking status, n (%)
Never1 (reference)
Former1.34 (1.20-1.51)< 0.001
Current1.08 (0.93-1.25)0.328
CHD, n (%)
No1 (reference)
Yes2.16 (1.82-2.56)< 0.001
Hypertension, n (%)
No1 (reference)
Yes2.24 (2.00-2.52)< 0.001
Calorie consumption (1000 kcal/d)0.83 (0.78-0.89)< 0.001
Protein consumption (g/1000 kcal/d)1.00 (1.00-1.00)0.965
Dietary fiber consumption (g/1000 kcal/d)0.98 (0.97-0.99)< 0.001
Dietary supplements taken, n (%)
No1 (reference)
Yes1.06 (0.95-1.17)0.313
Family history of diabetes, n (%)
No1 (reference)
Yes1.04 (0.93-1.16)0.487
Duration of diabetes (yr)1.04 (1.03-1.04)< 0.001
Insulin use, n (%)
No1 (reference)
Yes2.32 (2.03-2.64)< 0.001
Glucose-lowering drugs use, n (%)
No1 (reference)
Yes1.03 (0.92-1.15)0.576
HbA1c (%)1.15 (1.11-1.18)< 0.001
FPG (mmol/L)1.06 (1.04-1.07)< 0.001
FINS (μU/mL)1.00 (1.00-1.00)0.132
HOMA-IR1.01 (1.00-1.01)< 0.001
TC (mmol/L)0.95 (0.91-0.99)0.012
ALT (U/L)1.00 (0.99-1.00)0.019
AST (U/L)1.00 (1.00-1.00)0.816
SUA (µmol/L)1.00 (1.00-1.01)< 0.001
Hemoglobin (g/dL)0.81 (0.79-0.84)< 0.001